Will Clinical Trial Firm Icon Pass This Market Test?
Despite last week's sell-off on the Nasdaq and S&P 500, Ireland-based contract research organization (CRO) Icon has found support and shown resilience. Icon provides phase I - phase IV clinical trial services to pharmaceutical, biotech and medical device companies.